54 Results

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Houghton
    Houghton
  4. Wolchok
    Wolchok
  5. Scher
    Scher
  6. Ye
    Ye
  7. She
    She
  8. Chaganti
    Chaganti
  9. Motzer
    Motzer
  10. Perales
    Perales

Groups

  1. Department of Medicine (54)
  2. Sloan Kettering Institute Faculty (54)
  3. Solid Tumor Oncology Division (54)
  4. GSK Faculty (40)
  5. Molecular Pharmacology and Chemistry Program Faculty (36)
  6. Genitourinary Oncology Service (32)
  7. Breast Medicine Service (23)
  8. Human Oncology and Pathogenesis Program (21)
  9. Melanoma and Immunotherapeutics Service (14)
  10. Immunology Program Faculty (12)
  1. "Sloan Kettering Institute Faculty"
  2. "2006"
  3. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (21)
Groups
  1. Department of Medicine (54)
  2. Sloan Kettering Institute Faculty (54)
  3. Solid Tumor Oncology Division (54)
  4. GSK Faculty (40)
  5. Molecular Pharmacology and Chemistry Program Faculty (36)
  6. Genitourinary Oncology Service (32)

More Groups

People
  1. Neal Rosen (20)
  2. David Solit (17)
  3. Alan Houghton (11)
  4. Jedd Wolchok (10)
  5. Howard Scher (8)
  6. Qing Ye (6)

More People

Years
  1. 2006 (54)
Publications
  1. Cancer Research (10)
  2. Journal of Clinical Oncology (7)
  3. EJC Supplements (4)
  4. Annals of Oncology (2)
  5. Blood (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. American Society of Clinical Oncology (7)
  3. Oxford University Press (4)
  4. Pergamon-Elsevier Science Ltd (4)
  5. Nature Publishing Group (3)
  6. American Society for Clinical Investigation (2)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-specific serum peptidome patterns
    Meeting Abstract

    Tempst, P.; Villanueva, J.; Shaffer, D. R.; Martorella, A.; Robson, M. E.; Lawlor, K.; Philip, J.; Fleisher, M.; Lilja, H.; Holland, E. C.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • FLT PET as a non-invasive marker of response to MEK inhibition
    Meeting Abstract

    Solit, D. B.; Santos, E.; Pratilas, C. A.; Moroz, M.; Blasberg, R.; Sebolt-Leopold, J.; Larson, S.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of P13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • MAPK activation by B-RAF mutation or tyrosine kinase activation is associated with different patterns of feedback regulation that correlate with functional output of the pathway
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Sebolt-Leopold, J.; Rosen, N.; Solit, D. B.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • IGF-1 rescues rapamycin-induced cell growth inhibition
    Meeting Abstract

    O'reilly, K. E.; She, Q. B.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Solit, D.; Bagatell, R.; Ma, W.; Wheler, J.; Cropp, G. F.; Rosen, N.; Johnson, R. G. Jr; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Preclinical evaluation of fully synthetic Globo H cluster carbohydrate antigen as a cancer vaccine
    Meeting Abstract

    Koide, F.; Ragupathi, G.; Keding, S. J.; Allen, J.; Danishefsky, S. J.; Livingston, P. O.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 function downregulates EGFR and sensitizes EGFR-mutant xenografts to paclitaxel
    Meeting Abstract

    Sawai, A.; Greulich, H.; Ye, Q.; Sellers, W.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • B-RAF mutation is associated with altered patterns of negative feedback of MAPK signaling that correlate with increased output of the pathway and increased sensitivity to MEK inhibition
    Meeting Abstract

    Pratilas, C.; Grbovic, O.; Zhao, H.; Viale, A.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save